Apolipoprotein E-deficient mice are susceptible to the development of acute lung injury

Respiration

Volumn 87, Issue 5, 2014, Pages 416-427

  Yamashita, Cory M ^a   Fessler, Michael B ^b   Vasanthamohan, Lakshman ^a   Lac, Joanne ^a   Madenspacher, Jennifer ^a   McCaig, Lynda ^a   Yao, Lijuan ^a   Wang, Lefeng ^a   Puntorieri, Valeria ^a   Mehta, Sanjay ^a   Lewis, Jim F ^a   Veldhuizen, Ruud A W ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acid aspiration; Acute lung injury; Apolipoprotein E; Gastric acid aspiration; Hyperoxia; Oxidized low density lipoprotein

Indexed keywords

APOLIPOPROTEIN E; HYDROCHLORIC ACID; INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN; CXCL3 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; LOW DENSITY LIPOPROTEIN;

ACID ASPIRATION; ACUTE LUNG INJURY; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; HYPERLIPOPROTEINEMIA TYPE 3; HYPEROXIA; IN VIVO STUDY; INFLAMMATION; ISOLATED LUNG; LUNG ALVEOLUS CELL; LUNG ENDOTHELIUM; LUNG LAVAGE; LUNG PERFUSION; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ANIMAL TISSUE; CELL MEMBRANE PERMEABILITY; CHOLESTEROL BLOOD LEVEL; GENOTYPE; LIPID PEROXIDATION; LUNG CIRCULATION; LUNG VENTILATION; PROTEIN DEFICIENCY; VENTILATOR INDUCED LUNG INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; LUNG; METABOLISM; RESPIRATORY TRACT MUCOSA; SECRETION (PROCESS); TOXICITY;

ACUTE LUNG INJURY; ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HYDROCHLORIC ACID; INFLAMMATION; INTERLEUKIN-6; LIPOPROTEINS, LDL; LUNG; MICE; MICE, KNOCKOUT; PERMEABILITY; RESPIRATION, ARTIFICIAL; RESPIRATORY MUCOSA;

EID: 84899897841     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000358438     Document Type: Article

References (36)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
2. Lewis JF, Veldhuizen R: The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003; 65: 613-642.
3. Zemans RL, Matthay MA: Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury. Crit Care 2004; 8: 469-477.
4. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, et al: The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011; 37: 1932-1941.
5. Yamashita CM, Lewis JF: Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs 2012; 17: 1-4.
6. Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M, Hofker MH: Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin Chem Lab Med 2005; 43: 470-479.
7. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, et al: ICAM-1 deficiency reduces atherosclerotic lesions in doubleknockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 2000; 20: 2630-2635.
8. Moghadasian MH, McManus BM, Nguyen LB, Shefer S, Nadji M, et al: Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J 2001; 15: 2623-2630.
9. Ali K, Middleton M, Pure E, Rader DJ: Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 2005; 97: 922-927.
10. Ponnuswamy P, Schrottle A, Ostermeier E, Gruner S, Huang PL, et al: eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 2012; 7:e30193.
11. Weber C, Soehnlein O: ApoE controls the interface linking lipids and inflammation in atherosclerosis. J Clin Invest 2011; 121: 3825-3827.
12. Kato R, Mori C, Kitazato K, Arata S, Obama T, et al: Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29: 33-39.
13. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokineactivated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995; 95: 1262-1270.
14. Kitagawa K, Matsumoto M, Sasaki T, Hashimoto H, Kuwabara K, et al: Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis 2002; 160: 305-310.
15. Goldklang M, Golovatch P, Zelonina T, Trischler J, Rabinowitz D, et al: Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice. Am J Physiol Lung Cell Mol Physiol 2012; 302:L1200-L1208.
16. Yao X, Fredriksson K, Yu ZX, Xu X, Raghavachari N, et al: Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptormediated pathway. Am J Respir Crit Care Med 2010; 182: 1228-1238.
17. Walker MG, Tessolini JM, McCaig L, Yao LJ, Lewis JF, et al: Elevated endogenous surfactant reduces inflammation in an acute lung injury model. Exp Lung Res 2009; 35: 591-604.
18. Walker MG, Yao LJ, Patterson EK, Joseph MG, Cepinskas G, et al: The effect of tidal volume on systemic inflammation in acid-induced lung injury. Respiration 2011; 81: 333-342.
19. Martin EL, Sheikh TA, Leco KJ, Lewis JF, Veldhuizen RA: Contribution of alveolar macrophages to the response of the TIMP-3 null lung during a septic insult. Am J Physiol Lung Cell Mol Physiol 2007; 293:L779-L789.
20. Razavi HM, Wang le F, Weicker S, Rohan M, Law C, et al: Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med 2004; 170: 227-233.
21. Farley KS, Wang L, Mehta S: Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase. Am J Physiol Lung Cell Mol Physiol 2009; 296:L480-L488.
22. Arunachalam G, Sundar IK, Hwang JW, Yao H, Rahman I: Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond) 2010; 7: 34.
23. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC: Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995; 96: 107-116.
24. Knight PR, Druskovich G, Tait AR, Johnson KJ: The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology 1992; 77: 772-778.
25. O'Brien-Ladner AR, Nelson ME, Cowley BD Jr, Bailey K, Wesselius LJ: Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol 1995; 12: 275-279.
26. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, et al: Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol 1996; 157: 3902-3908.
27. Patterson EK, Yao LJ, Ramic N, Lewis JF, Cepinskas G, et al: Lung-derived mediators induce cytokine production in downstream organs via an NF-kappaB-dependent mechanism. Mediators Inflamm 2013; 2013: 586895.
28. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
29. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 282: 54-61.
30. Lin WC, Lin CF, Chen CL, Chen CW, Lin YS: Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med (Maywood) 2010; 235: 57-65.
31. Massaro D, Massaro GD: Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function. Am J Physiol Lung Cell Mol Physiol 2008; 294: L991-L997.
32. Chow SE, Hshu YC, Wang JS, Chen JK: Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 2007; 102: 1520-1527.
33. Wu Z, Sawamura T, Kurdowska AK, Ji HL, Idell S, et al: LOX-1 deletion improves neutrophil responses, enhances bacterial clearance, and reduces lung injury in a murine polymicrobial sepsis model. Infect Immun 2011; 79: 2865-2870.
34. van der Zwan LP, Teerlink T, Dekker JM, Henry RM, Stehouwer CD, et al: Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. J Lipid Res 2009; 50: 342-349.
35. Memtsoudis SG, Bombardieri AM, Ma Y, Walz JM, Chiu YL, et al: Mortality of patients with respiratory insufficiency and adult respiratory distress syndrome after surgery: the obesity paradox. J Intensive Care Med 2012; 27: 306-311.
36. Dossett LA, Heffernan D, Lightfoot M, Collier B, Diaz JJ, et al: Obesity and pulmonary complications in critically injured adults. Chest 2008; 134: 974-980.